NCT02740127 · ADVERSE EVENTS
Adverse events
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
Adverse events occurred during the study; they are not necessarily caused by treatment. Serious events are not interchangeable with severe/grade 3–4 events. These safety populations may differ from efficacy populations.
- Collection time frame
- 3 days post surgery
- Other-event reporting threshold
- 0%
| Safety group | Serious events | Other events | Deaths |
|---|---|---|---|
| General Anesthesia and Caudal Nerve Block | 0 / 24 | 0 / 24 | 0 / 24 |
| General Anesthesia Only | 0 / 28 | 0 / 28 | 0 / 28 |
Serious adverse events
Other reported adverse events
Complete source fields
- event Groups
- deaths Num Affected
- 0
- deaths Num At Risk
- 24
- description
- If the patient is randomized to Group I, the patient will receive general anesthesia using Propofol titrated for induction. The airway will be secured thereafter. The caudal block will be performed as a bolus injection into the caudal canal in the OR by the attending anesthesiologist using 1% Ropivacaine (max 5mg/kg) + 1:400,000 Epinephrine + Decadron 10mg + Clonidine 100mcg. Patients will be continuously monitored by ASA guidelines. Anesthesia will be maintained with Sevoflurane 1.3-2.5% or Desflurane 2.5-8.5%, oxygen, air, nitrous oxide and Fentanyl as needed. At the completion of surgery, reversal of muscle relaxant with Glycopyrrolate 0.2mg IV for each 1mg IV of Neostigmine (max 5mg) will be given as indicated.
- id
- EG000
- other Num Affected
- 0
- other Num At Risk
- 24
- serious Num Affected
- 0
- serious Num At Risk
- 24
- title
- General Anesthesia and Caudal Nerve Block
- deaths Num Affected
- 0
- deaths Num At Risk
- 28
- description
- Patients in Group II will receive general anesthesia using Propofol titrated for induction. The airway will be secured thereafter. Anesthesia will be maintained with Sevoflurane 1.3-2.5% or Desflurane 2.5-8.5%, oxygen, air, nitrous oxide and fentanyl as needed. At the completion of surgery, reversal of muscle relaxant with Glycopyrrolate 0.2mg IV for each 1mg IV of neostigmine (max 5mg) will be given as indicated.
- id
- EG001
- other Num Affected
- 0
- other Num At Risk
- 28
- serious Num Affected
- 0
- serious Num At Risk
- 28
- title
- General Anesthesia Only
- frequency Threshold
- 0
- time Frame
- 3 days post surgery
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice
Triangle